Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

A. S. Feils, A. K. Erbe, J. Birstler, K. Kim, U. Hoch, S. L. Currie, T. Nguyen, D. Yu, A. O. Siefker-Radtke, N. Tannir, S. M. Tolaney, A. Diab, P. M. Sondel

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences